Entest Group, Inc. (ETNI) financial statements (2020 and earlier)

Company profile

Business Address NO. 911 BAOAN BOOK CITY, XINQIAO STREET
SHENZHEN, 00000
State of Incorp. NV
Fiscal Year End August 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

11/30/2019
Q1
8/31/2019
Q4
5/31/2019
Q3
2/28/2019
Q2
11/30/2018
Q1
8/31/2018
Q4
5/31/2018
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments    00424
Cash and cash equivalents    00424
Prepaid expense     8108
Other undisclosed current assets  11111
Total current assets:  1119533
Noncurrent Assets
Prepaid expense      68
Other undisclosed noncurrent assets      78
Total noncurrent assets:      146
TOTAL ASSETS:  1119679
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:121113115210517
Accounts payable    228333
Accrued liabilities    3182184
Other undisclosed accounts payable and accrued liabilities12111311   
Debt     2017
Due to related parties3821146 88
Other undisclosed current liabilities     1777
Total current liabilities:513327165255618
Noncurrent Liabilities
Total liabilities:513327165255618
Stockholders' equity
Stockholders' equity attributable to parent, including:(51)(33)(26)(15)(1,006)(246)(1,051)
Common stock5555555
Additional paid in capital9,0259,0259,0259,0258,7298,7298,562
Accumulated other comprehensive income      73
Accumulated deficit(10,083)(10,065)(10,058)(10,047)(10,036)(10,256)(9,966)
Other additional capital    296275275
Other undisclosed stockholders' equity attributable to parent1,0021,0021,0021,002 1,002 
Stockholders' equity attributable to noncontrolling interest      110
Other undisclosed stockholders' equity    1,002 1,002
Total stockholders' equity:(51)(33)(26)(15)(4)(246)60
TOTAL LIABILITIES AND EQUITY:  1119679

Income statement (P&L) ($ in thousands)

11/30/2019
Q1
8/31/2019
Q4
5/31/2019
Q3
2/28/2019
Q2
11/30/2018
Q1
8/31/2018
Q4
5/31/2018
Q3
Revenues     (0) 
Cost of revenue (12)(8)(6)(194)(9)(9)
Gross profit: (12)(8)(6)(194)(9)(9)
Operating expenses(18)7(2)(5)179(281)(624)
Other undisclosed operating income     0 
Operating loss:(18)(4)(11)(11)(14)(290)(634)
Nonoperating income (expense) (2)  234(1)15
Investment income, nonoperating (6)     
Other nonoperating income (expense)    234(1)15
Interest and debt expense    24(0)(0)
Net income (loss):(18)(7)(11)(11)244(291)(619)
Other undisclosed net income (loss) attributable to parent    (24)00
Net income (loss) attributable to parent:(18)(7)(11)(11)220(291)(619)
Other undisclosed net income (loss) available to common stockholders, basic    (8)(467)249
Net income (loss) available to common stockholders, diluted:(18)(7)(11)(11)212(758)(370)

Comprehensive Income ($ in thousands)

11/30/2019
Q1
8/31/2019
Q4
5/31/2019
Q3
2/28/2019
Q2
11/30/2018
Q1
8/31/2018
Q4
5/31/2018
Q3
Net income (loss):(18)(7)(11)(11)244(291)(619)
Other comprehensive income      66
Other undisclosed comprehensive loss     (112) 
Comprehensive income (loss):(18)(7)(11)(11)244(403)(554)
Comprehensive loss, net of tax, attributable to noncontrolling interest      (249)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent    (24)225118
Comprehensive income (loss), net of tax, attributable to parent:(18)(7)(11)(11)220(178)(685)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: